Natco Pharma Limited

This company develops, manufactures, and markets pharmaceutical products for various segments, with a focus on oncology and specialty pharma.

1981 | Hyderabad, Telangana (India) | Active
Last Updated:

Natco Pharma Profile

Key Indicators

  • Authorised Capital ₹ 40.00 Cr
  • Paid Up Capital ₹ 35.82 Cr
  • Company Age 43 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 520.00 Cr
  • Satisfied Charges ₹ 1,277.71 Cr
  • Revenue Growth 30.83%
  • Profit Growth 358.02%
  • Ebitda 296.57%
  • Net Worth 12.17%
  • Total Assets 8.23%

About Natco Pharma

Natco Pharma Limited (NPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 19 September 1981 and has a history of 43 years and six months. Its registered office is in Hyderabad, Telangana, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524816 and on the National Stock Exchange(NSE) under NATCOPHARM.

The Corporate was formerly known as Natco Fine Pharmaceuticals Private Limited. The Company is engaged in the Agriculture Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 40.00 Cr and a paid-up capital of Rs 35.82 Cr.

The company currently has active open charges totaling ₹520.00 Cr. The company has closed loans amounting to ₹1,277.71 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Natco Pharma Limited India are S Rao as CFO and Venkat Chekuri as Company Secretary. Lakshminarayana Bolisetty, Agnihotra Chavali, Nitin Jain, and Six other members serve as directors at the Company.

Company Details

  • Location

    Hyderabad, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24230TG1981PLC003201

  • Company No.

    003201

  • Stock Symbol

    BSE : 524816 NSE : NATCOPHARM

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    19 Sep 1981

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Hyderabad

Industry

Agriculture
Pharma

What products or services does Natco Pharma Limited offer?

Natco Pharma Limited offers a wide range of products and services, including Common Disease Medicines, Steroid, Pain Relief Drugs & Pharmaceuticals, Pain Killers.

Who are the key members and board of directors at Natco Pharma?

Executive Team (3)

NameDesignationAppointment DateStatus
Venkaiah Nannapaneni Country flag representing In Managing Director01-Apr-2015Current
S Rao Country flag representing In CFO11-Feb-2016Current
Venkat Chekuri Company Secretary01-Apr-2022Current

Board Members (8)

NameDesignationAppointment DateStatus
Lakshminarayana Bolisetty Country flag representing In Director 12-Aug-2024Current
Agnihotra Chavali Country flag representing In Director 01-Apr-2024Current
Nitin Jain Country flag representing In Director 12-Aug-2024Current
Rajeev Nannapaneni Country flag representing Us Whole-Time Director 01-Jun-2012Current
Kantipudi Suma Country flag representing In Director 12-Aug-2024Current
Potluri Sivaramakrishna Country flag representing In Whole-Time Director 12-Nov-2014Current

Financial Performance of Natco Pharma.

Natco Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 30.83% increase. The company also saw a substantial improvement in profitability, with a 358.02% increase in profit. The company's net worth Soared by an impressive increase of 12.17%.

Natco Pharma revenue growth over time
Natco Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
30.83%
Revenue from Operations
32.99%
Total Assets
8.23%
Profit or Loss
358.02%
Net Worth
12.17%
EBITDA
296.57%

What is the Ownership and Shareholding Structure of Natco Pharma?

In 2022, Natco Pharma had a promoter holding of 48.81% and a public holding of 51.20%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹520.00 Cr

Satisfied Charges

₹1,277.71 Cr

Charges Breakdown by Lending Institutions

  • Others : 520.00 Cr

Latest Charge Details

DateLenderAmountStatus
08 Mar 2011Others₹520.00 CrOpen
18 Oct 2016Others₹50.00 CrSatisfied
22 Jun 2015Citi Bank N.A.₹12.05 CrSatisfied
22 Dec 2014Citi Bank N.A.₹60.00 CrSatisfied
10 May 2012Icici Bank Limited₹40.00 CrSatisfied

How Many Employees Work at Natco Pharma?

Natco Pharma has a workforce of 4466 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Natco Pharma Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Natco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Natco Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Natco Pharma

Recent activity within the organization

  • Annual General Meeting

    Natco Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Director Appointment

    Lakshminarayana Bolisetty was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 7 months 15 days .

  • Director Appointment

    Nitin Rameshwar Jain was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 7 months 15 days .

  • Director Appointment

    Kantipudi Suma was appointed as a Director was appointed as a Director on 12 Aug 2024 & has been associated with this company since 7 months 15 days .

  • Director Appointment

    Agnihotra Dakshina Murty Chavali was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 11 months 26 days .

  • Director Appointment

    Vijayabhaskar Dronadula was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 11 months 26 days .

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Natco Pharma Limited?

    Natco Pharma Limited was incorporated on 19 Sep 1981.

  • What is authorized share capital and paid-up capital of Natco Pharma Limited?

    The authorized share capital of Natco Pharma Limited is ₹ 40.00 Cr and paid-up capital is ₹ 35.82 Cr.

  • Who are the current board members & directors of Natco Pharma Limited?

    Currently 11 directors are associated with Natco Pharma Limited.

    • Lakshminarayana Bolisetty
    • Agnihotra Dakshina Murty Chavali
    • Nitin Rameshwar Jain
    • Venkaiah Chowdary Nannapaneni
    • Rajeev Nannapaneni
    • Kantipudi Suma
    • Potluri Prasad Sivaramakrishna
    • Lingarao Donthineni
    • Vijayabhaskar Dronadula
    • S V V N Appa Rao
    • Venkat Ramesh Chekuri

  • What is the registered address of Natco Pharma Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Natco Pharma Limited is Natco House Road No.2, Banjara Hills India, Hyderabad, Telangana, 500034.

  • What is the corporate identification number (CIN) and company number of Natco Pharma Limited?

    The corporate identification number (CIN) of Natco Pharma Limited is L24230TG1981PLC003201 and the company number is 003201 as per Ministry of Corporate Affairs (MCA).

  • Is Natco Pharma Limited registered with any stock exchange in India?

    Yes, Natco Pharma Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): NATCOPHARM.

  • What is the official website of Natco Pharma Limited?

    The Official website of Natco Pharma Limited is https://www.natcopharma.co.in

  • What has been the recent revenue trend for Natco Pharma Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Natco Pharma Limited has risen by 30.83%.

  • How many employees does Natco Pharma Limited currently have?

    As Per 2023 financial reports, 4466 employees are currently employed by Natco Pharma Limited.

  • What change has been observed in the net worth of Natco Pharma Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Natco Pharma Limited has experienced an upsurge of 12.17%.

  • What are the total open charges for Natco Pharma Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Natco Pharma Limited amount to ₹ 520.00 Cr.

  • When was the last Balance Sheet of Natco Pharma Limited filed with the ROC?

    The most recent Balance Sheet for Natco Pharma Limited was filed with the ROC on 31 Mar 2024.

People also Viewed